IP3R-III Antibodies

Santa Cruz Biotechnology delivers a wide array of IP3R-III monoclonal antibodies for research focused on understanding inositol trisphosphate receptors in cellular signaling. IP3R-III monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IP3R-III, or inositol trisphosphate receptor type 3, plays a crucial role in calcium signaling pathways, influencing processes such as cell proliferation, differentiation, and apoptosis. Its dysregulation has been implicated in various diseases, including cancer and neurodegenerative disorders, making it a significant target for therapeutic research. Understanding the function of IP3R-III is essential for elucidating the mechanisms of calcium-mediated signaling in health and disease. IP3R-III monoclonal antibodies enable precise detection and analysis of calcium signaling pathways across diverse experimental conditions. Researchers worldwide rely on IP3R-III monoclonal antibodies to advance cellular signaling studies and explore potential therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies continue to support breakthrough discoveries in calcium signaling research, contributing to advancements in understanding cellular communication and disease mechanisms.